Announcements Trials
Browse Landscape

Phase

Phase 2 316Phase 3 96Phase 1/2 91Phase 1 25Phase NA 10Phase 4 4Phase 2/3 4Phase EARLY_PHASE1 2

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 1

Conditions

Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Recurrence 1Lymphoma, Follicular 1Lymphoma 1Leukemia 1

Interventions

Paclitaxel 9Magnetic Resonance Spectroscopy 8Cyclophosphamide 8Cisplatin 8Carboplatin 8Granulocyte Colony-Stimulating Factor 7Etoposide 7Radiotherapy, Intensity-Modulated 6Nivolumab 6Leucovorin 6Filgrastim 6Drug Therapy 6Doxorubicin 6Radiotherapy 5Oxaliplatin 5Fluorouracil 5Docetaxel 5Bevacizumab 5pembrolizumab 4gallium 68 PSMA-11 4Taxes 4Sirolimus 4Rituximab 4Pemetrexed 4Melphalan 4Immunoglobulin G 4Gemcitabine 4Disulfides 4Dexamethasone 4Cytarabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Has results × Rituximab × Clear all
NCT01046825 2026-06-02

Mature B-Cell Lymphoma And Leukemia Study III

St. Jude Children's Research Hospital

Phase 2/3 Active not recruiting
128 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin

NCT02763319 2025-07-17

B-MIND

Incyte Corporation

Phase 2/3 Completed
453 enrolled 29 charts
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00096460 2023-01-05

BMT CTN 0202

Medical College of Wisconsin

Phase 2/3 Terminated
30 enrolled 5 charts
Lymphoid

Lymphoma, Follicular

NCT01197560 2019-11-25

Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Celgene

Phase 2/3 Completed
111 enrolled 20 charts
Lymphoid

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡